HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (8) Citing Articles via Google Scholar Google Scholar Articles by Nishigaki, Y. Articles by Kikuchi, K. Search for Related Content PubMed PubMed Citation Articles by Nishigaki, Y. Articles by Kikuchi, K.

Increased vascular endothelial growth factor in acute eosinophilic pneumonia

¹ Dept of Respiratory Medicine, National Dohoku Hospital, and ² The First ept of Internal Medicine, Asahikawa Medical College, Asahikawa, Japan

CORRESPONDENCE: Y. Nishigaki, Dept of Respiratory Medicine, National Dohoku Hospital, 7 Hanasaki, Asahikawa 078-8644, Japan. Fax: 81 166539184. E-mail: n.yhsoraroukou@gaea.ocn.ne.jp

Keywords: acute eosinophilic pneumonia, bronchoalveolar lavage, interleukin-5, vascular endothelial growth factor

Received: September 17, 2002
Accepted December 8, 2002

Acute eosinophilic pneumonia (AEP) is associated with the presence of diffuse pulmonary infiltrates on the chest radiograph and an increased number of eosinophils and an elevation of interleukin (IL)-5 levels in bronchoalveolar lavage (BAL) fluid. Vascular endothelial growth factor (VEGF) is a constitutively expressed protein encoded by messenger ribonucleic acid in human eosinophils and is released following stimulation with IL-5. However, the roles of IL-5 and VEGF in the pathogenesis or activity of this disease have not been clarified.

The authors investigated the cells and the levels of these two factors in BAL fluid in five AEP patients and five normal controls before and after corticosteroid treatment.

The absolute number of eosinophils·mL^–1, IL-5 and VEGF levels in patients before treatment were higher than in controls (53.8 versus 0.3x10⁴·mL^–1, 490.1 versus 5.2 pg·mL^–1 and 643.0 versus 133.9 pg·mL^–1, respectively). IL-5 and VEGF rapidly decreased to the control level in parallel with clinical improvement. The relationship between eosinophilia and IL-5 and VEGF levels was strongly significant.

Elevated interleukin-5 in the lung may initiate the recruitment of eosinophils and enhance the release of mediators, such as vascular endothelial growth factor from eosinophils, which, in turn, increases the permeability of blood vessels.

This article has been cited by other articles:

				U. Sack, M. Hoffmann, X. J. Zhao, K. S. Chan, D. S. C. Hui, H. Gosse, L. Engelmann, J. Schauer, F. Emmrich, and G. Hoheisel Vascular endothelial growth factor in pleural effusions of different origin Eur. Respir. J., April 1, 2005; 25(4): 600 - 604. [Abstract] [Full Text] [PDF]